Top 10 Best-Performing Healthcare Stocks YTD: ASPM, CYCC, SOMX, CDIC, GNVC, RNN, HDIX, AEN, IDEV, PCYC (Feb 18, 2010)
"Strong Buy" Rated U.S.-Listed Chinese Stocks (February 8, 2012)
Below are the top 10 best-performing Healthcare stocks year-to-date.
Aspect Medical Systems, Inc. (NASDAQ:ASPM) is the 1st best-performing stock year-to-date in this segment of the market. It has risen 259.82% since the beginning of this year. Its price percentage change is 269.58% for the last 52 weeks. Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) is the 2nd best-performing stock year-to-date in this segment of the market. It has risen 166.35% since the beginning of this year. Its price percentage change is 765.90% for the last 52 weeks. Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) is the 3rd best-performing stock year-to-date in this segment of the market. It has risen 158.33% since the beginning of this year. Its price percentage change is 27.98% for the last 52 weeks. CardioDynamics Int'l Corp (NASDAQ:CDIC) is the 4th best-performing stock year-to-date in this segment of the market. It has risen 137.17% since the beginning of this year. Its price percentage change is -4.29% for the last 52 weeks. GenVec, Inc. (NASDAQ:GNVC) is the 5th best-performing stock year-to-date in this segment of the market. It has risen 103.33% since the beginning of this year. Its price percentage change is 495.12% for the last 52 weeks.
Rexahn Pharmaceuticals, Inc. (AMEX:RNN) is the 6th best-performing stock year-to-date in this segment of the market. It has risen 95.59% since the beginning of this year. Its price percentage change is 90.00% for the last 52 weeks. Home Diagnostics, Inc. (NASDAQ:HDIX) is the 7th best-performing stock year-to-date in this segment of the market. It has risen 88.85% since the beginning of this year. Its price percentage change is 57.38% for the last 52 weeks. Adeona Pharmaceuticals, Inc. (AMEX:AEN) is the 8th best-performing stock year-to-date in this segment of the market. It has risen 82.14% since the beginning of this year. Its price percentage change is 466.67% for the last 52 weeks. Indevus Pharmaceuticals (NASDAQ:IDEV) is the 9th best-performing stock year-to-date in this segment of the market. It has risen 78.34% since the beginning of this year. Its price percentage change is 15.46% for the last 52 weeks. Pharmacyclics, Inc. (NASDAQ:PCYC) is the 10th best-performing stock year-to-date in this segment of the market. It has risen 75.16% since the beginning of this year. Its price percentage change is 674.65% for the last 52 weeks.